Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
Abbott LaboratoriesABT |
$60,000 |
 |
Tempus AITEM |
$75,000 |
 |
SolventumSOLV |
-$8,000 |
 |
HCA HealthcareHCA |
-$65,000 |
 |
ProgynyPGNY |
-$8,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rob Bresnahan | Feb 25, 2025 | Sell | $1K - $15K |
| Rohit Khanna Democrat | Apr 26, 2024 | Buy | $1K - $15K |
| Rohit Khanna Democrat | Oct 2, 2023 | Sell | $1K - $15K |
| Rohit Khanna Democrat | Aug 29, 2023 | Buy | $1K - $15K |
| Daniel S. Goldman Democrat | Jul 12, 2023 | Sell | $15K - $50K |
Who is the latest politician to buy or sell Teleflex shares?
Rob Bresnahan sold Teleflex shares most recently on February 25, 2025.
Which politician has bought the most TFX stock in the last two years?
Rohit Khanna has bought the most TFX stock in the last 2 years, with an estimated value of $16,000.
Which politician has sold the most TFX stock over the last two years?
Daniel S. Goldman has sold the most TFX stock in the last 2 years, with an estimated value of $33,000.
What is the total value of politicians trading TFX stock in the last 2 years?
The net value of trades by US politicians for Teleflex in the last 2 years is negative, amounting to -$33,000. This suggests that US politicians do not believe in the success of the company for various reasons.
How do insider transactions over the last 2 years reflect on Teleflex's market confidence?
Over the last 2 years, insider transactions for Teleflex have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering politicians might have insights or reasons not immediately apparent to the public.
Why should individual investors pay attention to the stock transactions of US politicians?
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
